These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30038441)

  • 1. RxLegal: A Rapid Review of Right-To-Try.
    Gabay M
    Hosp Pharm; 2018 Jul; 53(4):234-235. PubMed ID: 30038441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconciling States' "Right to Try" Legislation and FDA's Expanded Access Program: Legal Issues.
    Shapiro RS
    Ther Innov Regul Sci; 2017 Mar; 51(2):153-156. PubMed ID: 30231723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Federal Right to Try: Where Is It Going?
    Folkers K; Chapman C; Redman B
    Hastings Cent Rep; 2019 Mar; 49(2):26-36. PubMed ID: 30998281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Who Stands to Benefit? Right to Try Law Provisions and Implications.
    Kearns L; Bateman-House A
    Ther Innov Regul Sci; 2017 Mar; 51(2):170-176. PubMed ID: 30231728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ethical plausibility of the 'Right To Try' laws.
    Carrieri D; Peccatori FA; Boniolo G
    Crit Rev Oncol Hematol; 2018 Feb; 122():64-71. PubMed ID: 29458791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Congress Get 'Right to Try' Right?
    Kirkner RM
    Manag Care; 2018 May; 27(5):10-11. PubMed ID: 29763399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oversight of Right-to-Try and Expanded Access Requests for Off-Trial Access to Investigational Drugs.
    Chapman CR; Eckman J; Bateman-House AS
    Ethics Hum Res; 2020 Jan; 42(1):2-13. PubMed ID: 31967412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding Patient Access to Investigational Drugs: Single Patient Investigational New Drug and the "Right to Try".
    Van Norman GA
    JACC Basic Transl Sci; 2018 Apr; 3(2):280-293. PubMed ID: 30062214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
    Rossen BR
    Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical Negligence Determinations, the "Right to Try," and Expanded Access to Innovative Treatments.
    Meyerson D
    J Bioeth Inq; 2017 Sep; 14(3):385-400. PubMed ID: 28634770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding Patient Access to Investigational New Drugs: Overview of Intermediate and Widespread Treatment Investigational New Drugs, and Emergency Authorization in Public Health Emergencies.
    Van Norman GA
    JACC Basic Transl Sci; 2018 Jun; 3(3):403-414. PubMed ID: 30062226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free to Choose: A Moral Defense of the Right-to-Try Movement.
    Brodrick M
    J Med Philos; 2020 Jan; 45(1):61-85. PubMed ID: 31922578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right-to-try laws and individual patient "compassionate use" of experimental oncology medications: A call for improved provider-patient communication.
    Hoerger M
    Death Stud; 2016; 40(2):113-20. PubMed ID: 26313583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Right-to-Try Investigational Therapies for Incurable Disorders.
    Simmons Z
    Continuum (Minneap Minn); 2017 Oct; 23(5, Peripheral Nerve and Motor Neuron Disorders):1451-1457. PubMed ID: 28968371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marijuana in the Workplace: Guidance for Occupational Health Professionals and Employers: Joint Guidance Statement of the American Association of Occupational Health Nurses and the American College of Occupational and Environmental Medicine.
    Phillips JA; Holland MG; Baldwin DD; Gifford-Meuleveld L; Mueller KL; Perkison B; Upfal M; Dreger M
    Workplace Health Saf; 2015 Apr; 63(4):139-64. PubMed ID: 25862727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracking the trends. Year-end review of 1995 state actions on reproductive health policy. Abortion services.
    Sollom T
    State Reprod Health Monit; 1995 Dec; 6(4):1-3. PubMed ID: 12291286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Right to Try" Legislation Moving Through Congress: But Drug Companies and Some Patient Groups Want Changes.
    Barlas S
    P T; 2017 Dec; 42(12):739-763. PubMed ID: 29234212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. US state laws on medical freedom and investigational stem cell procedures: a call to focus on state-based legislation.
    Matthews KRW; Lowe SJ; Master Z
    Cytotherapy; 2024 Apr; 26(4):404-409. PubMed ID: 38310500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. United States laws and the rights of the terminally ill.
    Cowan DH
    Med Law; 2009 Sep; 28(3):519-29. PubMed ID: 20157966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.